Found: 6
Select item for more details and to access through your institution.
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion.
- Published in:
- Nature Communications, 2015, v. 6, n. 11, p. 10044, doi. 10.1038/ncomms10044
- By:
- Publication type:
- Article
Erratum to: Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 10, p. 1, doi. 10.1371/journal.ppat.1010662
- By:
- Publication type:
- Article
Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Nicastrin and Notch4 drive endocrine therapy resistance and epithelial-mesenchymal transition in MCF7 breast cancer cells.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 3, p. 1, doi. 10.1186/bcr3675
- By:
- Publication type:
- Article
Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
- Published in:
- 2014
- By:
- Publication type:
- journal article